Literature DB >> 13376914

Neutralizing and complement fixing antibody response to adenovirus infection.

J T GRAYSTON, P B JOHNSTON, C G LOOSLI, M E SMITH, R L WOOLRIDGE.   

Abstract

Entities:  

Keywords:  VIRUS DISEASES/immunology

Mesh：

Year:  1956        PMID： 13376914     DOI： 10.1093/infdis/99.2.199

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS.

Authors:  R WIGAND; H BAUER; F LANG; W ADAM
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  [Viruses in infections of the respiratory tract. 2].

Authors:  B MARTINEAU
Journal:  Can Med Assoc J       Date:  1961-01-07       Impact factor: 8.262

3.  Incidence of adenovirus infection: a family study.

Authors:  J JONCAS; A MOISAN; V AVILANIS
Journal:  Can Med Assoc J       Date:  1962-07-14       Impact factor: 8.262

4.  Epidemic keratoconjunctivitis.

Authors:  D H Wegman; V F Guinee; S J Milian
Journal:  Am J Public Health Nations Health       Date:  1970-07

5.  Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.

Authors:  J C Hierholzer; W C Gamble; W R Dowdle
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

6.  Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors.

Authors:  R J Huebner; M J Casey; R M Chanock; K Schell
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

7.  Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Authors:  Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos
Journal:  Vaccine       Date:  2006-01-24       Impact factor: 3.641

8.  Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.

Authors:  Robert Paris; Robert A Kuschner; Leonard Binn; Stephen J Thomas; Stefano Colloca; Alfredo Nicosia; Riccardo Cortese; Robert T Bailer; Nancy Sullivan; Richard A Koup
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

9.  Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine 1.

Authors:  Nakia S Clemmons; Zachary D McCormic; Joel C Gaydos; Anthony W Hawksworth; Nikki N Jordan
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.